Pancreatic Neoplasms: all 3,311 studies
Page 23 of 34. Open to participants first (911), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic CancerCompletedNCT03415802Phase 2
- A Study of ASN007 in Patients With Advanced Solid TumorsCompletedNCT03415126Phase 1
- Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic CancerCompletedNCT03412799Phase 1
- Patient Activation Through Counseling, Exercise and MobilizationCompletedNCT03411200Not applicable
- Optical and Biochemical Biomarkers in Early Pancreatic CancerCompletedNCT03404661
- Carbon Ion Radiation Therapy for Locally Advanced Pancreatic CancerCompletedNCT03403049Phase 1
- The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic CancerStatus unknownNCT03401827Phase 4
- POstopeRative Standardization of Care: THe Implementation of Best Practice After Pancreatic ResectionStatus unknownNCT03400280Not applicable
- Adapted Physical Activity in Patients With Resected Pancreatic Cancer (APACaPOp PRODIGE-56 Study): a National Multicenter Randomized Controlled Phase II TrialStatus unknownNCT03400072Not applicable
- Phase II Study of NGC-Triple Regimen in Potentially Resectable Pancreatic Cancer PatientsWithdrawnNCT03392571Phase 2
- Combination of Radiation Therapy and Anti-PD-1 Antibody in Treating Patients With Pancreatic CancerStatus unknownNCT03374293Phase 2
- VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal CancerCompletedNCT03373188Phase 1
- TAS102 in Combination With NAL-IRI in Advanced GI CancersActive, not recruitingNCT03368963Phase 1/2
- Biliary Drainage Preceding Possible Pancreaticoduodenectomy. Are Self-expandable Metallic Stents (SEMS) Superior to Plastic Stents?WithdrawnNCT03350763Not applicable
- Muscle Dysfunction in Gastrointestinal or Hepatobiliary CancerActive, not recruitingNCT03347162
- Role of CTC´s Spread During Pancreaticoduodenectomy in Patients With Pancreatic and Periampullary TumorsCompletedNCT03340844Not applicable
- PENS or TENS for Pain in Pancreatic CancerCompletedNCT03331055Not applicable
- Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine TumoursTerminatedNCT03328065
- CAR T Cell Immunotherapy for Pancreatic CancerTerminatedNCT03323944Phase 1
- Celiac Plexus Radio-Surgery for Pain ManagementCompletedNCT03323489Not applicable
- EUS-FNB With ROSE Vs. EUS-FNB Without ROSECompletedNCT03322592Not applicable
- Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic CancerCompletedNCT03316599Phase 1
- Connect Your Needle to Your Phone to Increase EUS FNA Diagnostic Yield?CompletedNCT03303352Not applicable
- Oral Microbiome and Pancreatic CancerCompletedNCT03302637
- Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant TumorsStatus unknownNCT03302403Not applicable
- A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic Cancer A Phase Ib Pharmacodynamic Study of Neoadjuvant Paricalcitol in Resectable Pancreatic CancerTerminatedNCT03300921Phase 1
- IACS-010759 in Advanced CancersCompletedNCT03291938Phase 1
- Phase 1 Trial of Interleukin 12 Gene Therapy for Metastatic Pancreatic CancerCompletedNCT03281382Phase 1
- Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer PatientsStatus unknownNCT03278015Phase 2
- To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal AdenocarcinomasTerminatedNCT03277209Phase 1
- The Effect of Application of TachoSil® in PancreatoduodenectomyStatus unknownNCT03269955Phase 4
- BATs Treatment for Pancreatic Cancer, Phase Ib/IICompletedNCT03269526Phase 1/2
- Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family CaregiversCompletedNCT03267524Not applicable
- Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer.Status unknownNCT03267173Early Phase 1
- Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder CancerActive, not recruitingNCT03257761Phase 1
- Exercise and Nutrition to Improve Pancreatic Cancer OutcomesActive, not recruitingNCT03256201Not applicable
- Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients with Unresectable Pancreatic Cancer.Active, not recruitingNCT03252808Phase 1
- Effects of Epidural Anesthesia and Analgesia on the Prognosis in Patients Undergoing Pancreatic Cancer SurgeryCompletedNCT03245346Not applicable
- Bioinformation Therapy for Pancreatic CancerCompletedNCT03239184Phase 2/3
- Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Pancreatic CancerStatus unknownNCT03236883Phase 1
- Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic CancerTerminatedNCT03225781Not applicable
- Cardiopulmonary Exercise Testing: An Assessment of Patients Fitness for Palliative Chemotherapy for Pancreatic CancerStatus unknownNCT03215459
- Circulating Tumor DNA as a Prognostic Marker in Patients With Pancreatic CancerStatus unknownNCT03214991
- Conventional Versus Elastography Targeted Endoscopic Ultrasound Fine Needle Aspiration of Solid Pancreatic LesionsStatus unknownNCT03210948Not applicable
- International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)Status unknownNCT03210298
- Study of Onivyde and 5-FU in Combination With Xilonix for Pancreatic Cancer With CachexiaCompletedNCT03207724Phase 1
- AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including LymphomasCompletedNCT03205176Phase 1
- An Open Label Study to Evaluate G17DT Compared to GemcitabineCompletedNCT03200821Phase 3
- Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor MalignanciesCompletedNCT03199586Phase 1
- Neoadjuvant Chemotherapy and Stereotactic Radiosurgery to Pancreatectomy for Patients With Borderline Resectable Pancreatic CancerWithdrawnNCT03199144Phase 2
- PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic CancerActive, not recruitingNCT03187951Not applicable
- Diet and Exercise After Pancreatic CancerCompletedNCT03187028Not applicable
- Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in Cystic Tumors of the PancreasStatus unknownNCT03182270Not applicable
- Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic CancerCompletedNCT03180437Phase 1/2
- Two Cancers, One Gene. Why Some People in Families Develop Melanoma or Pancreas Cancer, While Still Others Never Develop Cancer.CompletedNCT03174574
- A Pan-European Study on Minimally Invasive Versus Open Pancreatoduodenectomy in High-volume CentersCompletedNCT03172572
- 18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in PatientsActive, not recruitingNCT03168737Phase 1
- Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic CancerCompletedNCT03168139Phase 1/2
- A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic CancerStatus unknownNCT03167112Phase 2
- RFA for Malignant Biliary ObstructionStatus unknownNCT03166436Not applicable
- Open Label Immunotherapy Trial of Inoperable Pancreatic CancerStatus unknownNCT03165591Phase 1/2
- First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-PeptideActive, not recruitingNCT03164486Early Phase 1
- Evaluation of SBRT for Patients With Locally Advanced Unresectable Pancreatic CancerCompletedNCT03158779Phase 2
- Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus NeurolysisCompletedNCT03152487Not applicable
- Enteral Nutrition After PancreaticoduodenectomyCompletedNCT03150615Not applicable
- Laser Tissue Welding - Distal Pancreatectomy Sealing StudyCompletedNCT03147768Phase 1
- Pancreatic Cancer Models Developed From EUS Guided Biopsy TissueStatus unknownNCT03140592
- A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous ThromboembolismStatus unknownNCT03139487Phase 2
- Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon CancerTerminatedNCT03137706
- Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)CompletedNCT03133286
- Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as RadioimmunotherapyTerminatedNCT03118349Phase 1
- A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic CancerCompletedNCT03117920Phase 2
- Bilateral Thoracoscopic Splanchnicectomy for Pain Relief in Patients With Unresectable Pancreatic CancerWithdrawnNCT03117556Not applicable
- Dendritic Cell Immunotherapy for the Patients With Pancreatic CancerCompletedNCT03114631Phase 1/2
- EUS-FNA of Solid Pancreatic Mass: Comparison Between Negative Pressure and Slow-pull TechniqueCompletedNCT03111368Not applicable
- Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR SourceCompletedNCT03109041Phase 1
- Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic CancerActive, not recruitingNCT03104439Phase 2
- A Phase I Trial of LY3143921 Hydrate in Solid TumoursCompletedNCT03096054Phase 1
- Study of Talimogene Laherparepvec (T-VEC) in Pancreatic CancerCompletedNCT03086642Phase 1
- Oncologic Outcomes Based on Clinical Pattern of Preoperative PET-CT in Resected Pancreatic CancerCompletedNCT03077334
- The Role of ctDNA, PVT1 and ROS in Diagnosis and Treatment of Gastrointestinal and Hepatobiliary Pancreatic CancerStatus unknownNCT03076502
- A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With Gemcitabine +/- Nab-paclitaxel.CompletedNCT03076216Not applicable
- Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic CancerActive, not recruitingNCT03073785Phase 2
- Palliative Pancreatic Duct Stenting in Patients With Inoperable Pancreatic CancerStatus unknownNCT03069664Not applicable
- Immune Response After Pancreatic Cancer TreatmentTerminatedNCT03069599
- Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid TumorsSuspendedNCT03065062Phase 1
- EUS BD vs ERCP TP for Pancreatic CancerStatus unknownNCT03063554Not applicable
- Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized TherapyActive, not recruitingNCT03060720
- Coordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic CancerStatus unknownNCT03058926
- Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for Malignant Distal Biliary ObstructionCompletedNCT03054987Not applicable
- Relation Between Cachexia, Diabetes and periNeural Invasion in PANcreatic Cancer- Biomarkers SubstudyCompletedNCT03042442
- Predicting Effective Therapy in Pancreatic CancerActive, not recruitingNCT03033927
- Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)CompletedNCT03017690
- Translational Research on Locally Advanced Pancreatic AdenocarcinomaStatus unknownNCT03009253Not applicable
- High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic CancerCompletedNCT03008304Phase 1/2
- A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+AbraxaneCompletedNCT03003078Not applicable
- Autologous Cytokine-induced Killer Cells Combined Chemotherapy in Advanced Pancreatic CancerTerminatedNCT03002831Phase 2
- Immunologic Signatures Following Surgery for Pancreatic CancerCompletedNCT03001518
- Registry for Pancreatic CancerWithdrawnNCT03001505
- Study of Induction Chemotherapy Followed by Radiochemotherapy in Locally Advanced Pancreatic CancerCompletedNCT02984501Phase 2